Post Cancer Survivorship
So Becky over at BC Becky blogged aboutdeveloping her post cancer survivorship plan. (Personally, I hate the S word but will suffer through it for this blog post, using it as Becky's word not mine.) Other people call it their new'normal'. I have found it very elusive. And basically think its a crock of sh*t. However this morning I started thinking (which is dangerous) while reading Becky's post.I have no way of reaching a new normal because I was living my new normal, post cancer since 1981. I have no way of knowing what it would be like to be an adult without cancer since I was 19 and in college at my first diagnosis.I always forget this. I am not sure how I am capable of forgetting this. I think I keep going on the bandwagon of let's find our new normal. But I was already living the post cancer'new normal'. This begs the question is it possible to reach a'new normal'for a second time?Along with hating the S word I also have a problem with the blankety-blank'new normal'concept. But in this case, I may have found the reason why I hate this so much because I have been living it all along.So this begs the question, what would I be like without cancer? I have no idea because I never really had the change. So you are stuck with me and my post cancer self.
In conclusion, the addition of PPIs to the treatment regimen of breast cancer appears to be a promising strategy to potentiate the efficacy of chemotherapy and may suppress cancer metastasis. PMID: 31955147 [PubMed - in process]
Abstract A series of nine new 2,3-disubstituted 4(3H)-quinazolin-4-one derivatives was furnished starting from the 2-propyl-4(3H)-quinazo-line-4-one (2). The reinvestigation of the key starting quinazolinone 2 was performed under microwave irradiation (MW) and solvent-free conditions. Combination of MW and phase-transfer catalysis using tetrabutylammonium benzoate (TBAB) as a novel neutral ionic catalyst was used for carrying out N-alkylation and condensation reactions of compound 2 as a simple, efficient and eco-friendly technique. The structure of the synthesized compounds was elucidated using different spectral...
Cancer Research UK scientists working in Cambridge made a vital energy-producing chemical magnetic and used MRI scans to watch how quickly breast cancer cells used it up.
I am currently in my senior year of undergrad, and i honestly don't know what my chances of getting into a mid-tier medical school is since my scores are kinda low average. I personally feel i am a little different because im ADHD and Dyslexic and coupled with my experience as a whole. Currently, i have a 3.4 overall GPA scored a 505 on the MCAT The second author on Triple-negative Metaplastic Breast Cancer research paper. I work full time as a Regional Representative for a hemp company... WAMC since i am out the ordinary case
Breast cancer progression can vary significantly between patients. Even within the same tumor, different areas may be composed of different types of cells and characterized by different tumor structures. This heterogeneity makes it challenging to ascertain the severity of a tumor and assess its molecular subtype, thereby affecting the precision of diagnosis and the choice of the most effective treatment approach.
(Cancer Research UK) A new type of scan that involves magnetizing molecules allows doctors to see in real-time which regions of a breast tumor are active, according to research funded by Cancer Research UK and published in Proceedings of the National Academy of Sciences today. This is the first time researchers have demonstrated that this scanning technique, called carbon-13 hyperpolarized imaging, can be used to monitor breast cancer.
(University of Zurich) An imaging approach developed at UZH enables the study of breast cancer tissue in greater detail. It uses 35 biomarkers to identify the different cell types in breast tumors and its surrounding area compared to the current standard of testing single markers. This increases the precision of tumor analysis and classification - and improves personalized diagnostics for breast cancer patients.